New Delhi: Drugmaker Mylan NV said on Monday it secured approval to launch its generic version of Gilead Sciences Inc's Covid-19 treatment drug remdesivir in India this month at ₹4,800 per 100 mg vial, as infections surge in the world's third worst-hit country by the virus.
The Drug Controller General of India (DCGI) approved Mylan's remdesivir version, to be launched under brand name Desrem, for restricted emergency use in Covid-19 patients, the company said in a statement
Mylan secured regulatory approval for remdesivir lyophilized powder for injection of 100 mg/vial for restricted emergency use.
Mylan's version comes after two Indian drugmakers, Cipla Ltd and privately-held Hetero Labs Ltd, launched their generic versions of the drug.
Cipla will price its version, Cipremi, at less than ₹5,000, while Hetero has priced its version, Covifor, at ₹5,400.
Gilead has priced remdesivir at $2,340 per patient for wealthier nations. It has agreed to send nearly all of its supply of the drug to the United States over the next three months, stirring concerns about availability elsewhere.
Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial. On Friday, it got conditional approval from the European Commission for use in severe COVID-19 patients.
Mylan NV said Mylan will manufacture remdesivir in India at its injectables' facilities. The drug has been approved in India for the treatment of suspected or laboratory confirmed severe incidences of COVID-19 in adults and children, the company said in a statement.
Gilead has signed licensing agreements with India's Dr.Reddy's Laboratories Ltd, Jubilant Life Sciences Ltd, Syngene International Ltd and Zydus Cadila, listed as Cadila Healthcare Ltd, to make and sell remdesivir.
The Union Health Ministry on Friday has revised the dosage of the antiviral drug--remdesivir, being administered to hospitalized Covid-19 patients from the earlier six-days to five-day treatment course.
According to the Health Ministry, remdesivir drug is only for restricted emergency use on patients with moderate disease (those on oxygen support). The drug cannot be administered to a pregnant or lactating mother and children below the age of 12 years. Also, the drug is not recommended to a patient with severe renal impairment and a high level of liver enzymes.
The Central Health Ministry has issued a fresh clinical management protocol for COVID-19 patients on Friday. In the latest protocol, the ministry has informed the dosage of remdesivir should be-- 200 mg IV on day 1 followed by 100 mg IV daily for 4 days (5 days in total). However, in the previous clinical protocol issued on June 13, the Health Ministry stated that the patient has to be administered with 200 mg IV on day 1 followed by 100 mg IV daily for 5 days, that was, 6 days in total.
May 14, 2020 0 3637
Oct 20, 2020 0 7263
Jun 22, 2020 0 1241
Mar 25, 2021 0 17175
Oct 23, 2020 0 1910
Apr 4, 2021 0 27184
Nov 22, 2019 0 2131
Two of the petrol offerings in the car include a 1.2-litre Kappa dual VTVT engine...
Aug 22, 2019 0 1071
The beta version of PUBG Mobile in China has got a new mode which lets you fly helicopters,...
Sep 14, 2021 0 214
Mar 13, 2021 0 283
The idol of Lord Shiva will be moved out of its winter abode at Ukhimath's Omkareshwar...
Aug 26, 2019 0 6
Untouched by the outside world, Pulga has kept its local charm alive owing to its...
Oct 30, 2019 0 2467
Combining detection software, observation, and player reporting, the developers...
Oct 5, 2019 0 2765
Early leaks have revealed upcoming in-game items and RP Rewards that will be arriving...
Sep 2, 2019 0 1538
The car is powered by Mahindra’s 2.5-litre, m2Di, four-cylinder, diesel engine providing...
Aug 22, 2019 0 1154
Varun Dhawan and Natasha Dalal have been dating for many years.
Aug 30, 2019 0 1233
Tata Power has 85 EV charging stations spread in 15 cities across 9 states including...
Sep 14, 2021 0 493
Sep 14, 2021 0 406
Sep 14, 2021 0 214
Sep 1, 2021 0 12829
Jun 2, 2020 0 74
Jul 22, 2022 0 59
Jul 22, 2022 0 28
Oct 30, 2019 0 12
Aug 9, 2021 2 12